The "Nativita" Scientific and Production Complex opened in Beshenkovichi
A modern, high-tech complex has been built here, designed and created with the assistance of expert consultants from the European Union and CIS countries. Special isolation technologies ensure a high level of quality for the manufactured products, as well as the safety of personnel and the environment.
The production capabilities allow for the manufacturing of medicinal products (in tablet, capsule, and liquid forms) through a full cycle in accordance with the requirements of the European GMP standard. The pharmaceutical enterprise is primarily focused on the development and production of innovative drugs for the treatment of oncological diseases. The enterprise has created a unique site for Belarus, where cytostatic drugs in solid forms are produced using isolators from the Italian company Nicomac. It is noteworthy that even before the production launch, "Nativita" registered and sold its medicines in Belarus.
Filling and packaging were carried out at the Belarusian enterprise "Academpharm," but in the future, they will be produced at the pharmaceutical plant in Beshenkovichi. The company has 13 registered products to its credit. It is planned that in 2017, this list will expand to 20 drugs. The company's ambitious plans are not limited to mastering the Belarusian market. In 2017, the enterprise will begin registering medicinal products in the EU countries. There are agreements on the registration of drugs in the markets of Vietnam, Azerbaijan, Kazakhstan, Russia, Iraq, and Syria. In general, "Nativita" has 15 countries within its export interests.